Phreesia, Inc. (NYSE:PHR) SVP Sells $321,103.80 in Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 11,685 shares of the company’s stock in a transaction that occurred on Monday, January 27th. The shares were sold at an average price of $27.48, for a total value of $321,103.80. Following the completion of the transaction, the senior vice president now directly owns 231,271 shares in the company, valued at $6,355,327.08. This trade represents a 4.81 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

David Linetsky also recently made the following trade(s):

• On Wednesday, December 18th, David Linetsky sold 24 shares of Phreesia stock. The stock was sold at an average price of $25.38, for a total value of $609.12.
• On Monday, December 16th, David Linetsky sold 35 shares of Phreesia stock. The shares were sold at an average price of $24.88, for a total value of $870.80.
• On Wednesday, December 11th, David Linetsky sold 11,853 shares of Phreesia stock. The stock was sold at an average price of $24.85, for a total value of $294,547.05.

Phreesia Stock Performance

Shares of NYSE PHR traded down $0.49 during trading on Wednesday, hitting $28.81. The company had a trading volume of 384,950 shares, compared to its average volume of 392,842. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $29.90. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The firm has a market capitalization of $1.67 billion, a P/E ratio of -19.60 and a beta of 0.94. The stock has a 50 day simple moving average of $24.57 and a 200 day simple moving average of $23.20.

Phreesia (NYSE:PHR) last released its earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm’s revenue was up 16.6% compared to the same quarter last year. During the same quarter last year, the business earned ($0.58) EPS. As a group, analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on PHR shares. KeyCorp raised their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Citigroup lifted their target price on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. Needham & Company LLC reissued a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Friday, January 10th. Truist Financial raised their price target on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Thirteen investment analysts have rated the stock with a buy rating, According to MarketBeat, Phreesia has an average rating of “Buy” and a consensus price target of $31.15.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Hsbc Holdings PLC bought a new position in shares of Phreesia in the second quarter worth about $301,000. Sei Investments Co. lifted its holdings in Phreesia by 135.3% in the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after purchasing an additional 95,058 shares in the last quarter. Squarepoint Ops LLC boosted its stake in Phreesia by 56.3% in the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock worth $5,308,000 after purchasing an additional 90,215 shares during the period. SG Americas Securities LLC purchased a new stake in Phreesia during the 3rd quarter valued at approximately $954,000. Finally, Diversified Trust Co raised its position in shares of Phreesia by 12.9% during the third quarter. Diversified Trust Co now owns 24,356 shares of the company’s stock valued at $555,000 after buying an additional 2,782 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.